Th17 Cells in Depression

Overview

Journal Brain Behav Immun

Publisher Elsevier

Specialties Allergy & Immunology
Neurology
Psychiatry

Date 2017 Aug 7

PMID 28779999

Citations 75

Authors

Eleonore Beurel

Jeffrey A Lowell

Affiliations

Soon will be listed here.

Abstract

T helper 17 (Th17) cells have recently been implicated in depression, which adds to the list of several other diseases of the central nervous system (CNS) that are already known to involve Th17 cells. In CNS diseases, it is thought that the signature cytokine produced by Th17 cells, interleukin-17A (IL-17A), mediates the detrimental effects of Th17 cells. In depression, although Th17 cells increase, the lack of a consistent correlation between depression severity and blood IL-17A levels suggests that Th17 cells promote depressive symptoms, which may not be entirely dependent on IL-17. However, little is known about the mechanism of action of Th17 cells or the source of CNS Th17 cells in depression. It is likely that Th17 cells promote neuroinflammation and activation of microglia and astrocytes, actions that may contribute to neuronal damage. A source of Th17 cells is the small intestine where they are regulated by the composition of the microbiome. It remains to be determined through what mechanisms of action Th17 cells affect depression and if Th17 cells can be considered a novel therapeutic target in depression.

Citing Articles

The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation.

Yu W, Sun S, Fu Q Front Immunol. 2025; 16:1519925.

PMID: 39991152 PMC: 11842938. DOI: 10.3389/fimmu.2025.1519925.

Interaction between Th17 and central nervous system in multiple sclerosis.

Lai S, Wu X, Liu Y, Liu B, Wu H, Ma K Brain Behav Immun Health. 2025; 43():100928.

PMID: 39845807 PMC: 11751430. DOI: 10.1016/j.bbih.2024.100928.

Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model.

van Baalen M, van der Velden L, van der Gronde T, Pieters T Front Psychiatry. 2025; 15():1463929.

PMID: 39839132 PMC: 11747824. DOI: 10.3389/fpsyt.2024.1463929.

Gut-brain axis as a bridge in obesity and depression: Mechanistic exploration and therapeutic prospects.

Fang R, Pan X, Zeng X, Li Z, Chen B, Zeng H World J Psychiatry. 2025; 15(1):101134.

PMID: 39831021 PMC: 11684226. DOI: 10.5498/wjp.v15.i1.101134.

Impact of the gut microbiota-Th17 cell axis on inflammatory depression.

Jia X, Wang J, Ren D, Zhang K, Zhang H, Jin T Front Psychiatry. 2024; 15:1509191.

PMID: 39655201 PMC: 11625820. DOI: 10.3389/fpsyt.2024.1509191.

References

Miller A, Raison C . The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2015; 16(1):22-34. PMC: 5542678. DOI: 10.1038/nri.2015.5. View

Colpitts S, Kasper L . Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System. J Immunol. 2017; 198(2):596-604. DOI: 10.4049/jimmunol.1601438. View

Bautista J, Foldvary-Schaefer N, Bingaman W, Luders H . Focal cortical dysplasia and intractable epilepsy in adults: clinical, EEG, imaging, and surgical features. Epilepsy Res. 2003; 55(1-2):131-6. DOI: 10.1016/s0920-1211(03)00118-9. View

Jankovic D, Kugler D, Sher A . IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 2010; 3(3):239-46. PMC: 4105209. DOI: 10.1038/mi.2010.8. View

Yang J, Sundrud M, Skepner J, Yamagata T . Targeting Th17 cells in autoimmune diseases. Trends Pharmacol Sci. 2014; 35(10):493-500. DOI: 10.1016/j.tips.2014.07.006. View

Zimmermann J, Krauthausen M, Hofer M, Heneka M, Campbell I, Muller M . CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia. PLoS One. 2013; 8(2):e57307. PMC: 3584143. DOI: 10.1371/journal.pone.0057307. View

Hernandez-Santos N, Gaffen S . Th17 cells in immunity to Candida albicans. Cell Host Microbe. 2012; 11(5):425-35. PMC: 3358697. DOI: 10.1016/j.chom.2012.04.008. View

Louveau A, Harris T, Kipnis J . Revisiting the Mechanisms of CNS Immune Privilege. Trends Immunol. 2015; 36(10):569-577. PMC: 4593064. DOI: 10.1016/j.it.2015.08.006. View

Zhang Y, Zhen H, Yao W, Bian F, Mao X, Yang X . Antidepressant drug, desipramine, alleviates allergic rhinitis by regulating Treg and Th17 cells. Int J Immunopathol Pharmacol. 2013; 26(1):107-15. DOI: 10.1177/039463201302600110. View

10.

Ivanov I, McKenzie B, Zhou L, Tadokoro C, Lepelley A, Lafaille J . The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006; 126(6):1121-33. DOI: 10.1016/j.cell.2006.07.035. View

11.

Kugelberg E . Neuroimmunology: IL-17A mediates a path to autism. Nat Rev Immunol. 2016; 16(4):205. DOI: 10.1038/nri.2016.35. View

12.

Vezzani A . Inflammation and epilepsy. Epilepsy Curr. 2005; 5(1):1-6. PMC: 1176317. DOI: 10.1111/j.1535-7597.2005.05101.x. View

13.

Fung T, Olson C, Hsiao E . Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017; 20(2):145-155. PMC: 6960010. DOI: 10.1038/nn.4476. View

14.

Moynes D, Vanner S, Lomax A . Participation of interleukin 17A in neuroimmune interactions. Brain Behav Immun. 2014; 41:1-9. DOI: 10.1016/j.bbi.2014.03.004. View

15.

Lee Y, Awasthi A, Yosef N, Quintana F, Xiao S, Peters A . Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012; 13(10):991-9. PMC: 3459594. DOI: 10.1038/ni.2416. View

16.

Choi G, Yim Y, Wong H, Kim S, Kim H, Kim S . The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016; 351(6276):933-9. PMC: 4782964. DOI: 10.1126/science.aad0314. View

17.

Muranski P, Restifo N . Essentials of Th17 cell commitment and plasticity. Blood. 2013; 121(13):2402-14. PMC: 3612853. DOI: 10.1182/blood-2012-09-378653. View

18.

Hirota K, Duarte J, Veldhoen M, Hornsby E, Li Y, Cua D . Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol. 2011; 12(3):255-63. PMC: 3040235. DOI: 10.1038/ni.1993. View

19.

Hu M, Zheng Q, Jia X, Li Y, Dong Y, Wang C . Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation. Clin Exp Immunol. 2013; 175(2):268-84. PMC: 3892418. DOI: 10.1111/cei.12219. View

20.

Powell N, Walker M, Talley N . The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol. 2017; 14(3):143-159. DOI: 10.1038/nrgastro.2016.191. View